Drugs / Gymnema
last change Mar 2018 re-read 2 minutes ago

Gymnema

Developed for
type 2 diabetes mellitus · vascular disorder

Trials 0

Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT03676309 Comparator Sep 2017 → Mar 2018 type 2 diabetes mellitus, vascular disorder Villa dei Gerani Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Gymnema “nutraceutical 920 mg (Bergamot 450 mg, Gymnema (400 mg, Phaseolamine 30 mg, Olea Europaea 10 mg) twice day , 12 weeks” NCT03676309